This review highlights the benefits of interventions such as NLRP3 inflammasome-targeted therapy to improve ectopic fat tissue dysfunction, anti-aging treatments, aerobic exercise, respiratory muscle strength training, dietary modifications, and even bariatric surgery for IPF patients. This evidence concerns the gene NLRP3 and idiopathic pulmonary fibrosis.